Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Plastics in Medical Devices: Properties, Requirements, and Applications
    Unavailable
    Plastics in Medical Devices: Properties, Requirements, and Applications
    Unavailable
    Plastics in Medical Devices: Properties, Requirements, and Applications
    Ebook700 pages5 hours

    Plastics in Medical Devices: Properties, Requirements, and Applications

    By Vinny R. Sastri

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Plastics in Medical Devices is a comprehensive overview of the main types of plastics used in medical device applications. It focuses on the applications and properties that are most important in medical device design, such as chemical resistance, sterilization capability and biocompatibility. The roles of additives, stabilizers, and fillers as well as the synthesis and production of polymers are covered and backed up with a wealth of data tables.

    Since the first edition the rate of advancement of materials technology has been constantly increasing. In the new edition Dr. Sastri not only provides a thorough update of the first edition chapters with new information regarding new plastic materials, applications and new requirements, but also adds two chapters – one on market and regulatory aspects and supplier controls, and one on process validation. Both chapters meet an urgent need in the industry and make the book an all-encompassing reference not found anywhere else.

    • Comprehensive coverage of uses of polymers for medical devices
    • Unique coverage of medical device regulatory aspects, supplier control and process validation
    • Invaluable guide for engineers, scientists and managers involved in the development and marketing of medical devices and materials for use in medical devices
    LanguageEnglish
    PublisherElsevier Science
    Release dateNov 27, 2013
    ISBN9780323265638
    Unavailable
    Plastics in Medical Devices: Properties, Requirements, and Applications
    Author

    Vinny R. Sastri

    Vinny Sastri, Ph.D., is the President of Winovia, LLC, a consultancy company specializing in quality management systems, notably in the area of medical devices. Dr. Sastri’s areas of expertise include FDA and ISO quality management systems for medical devices and pharmaceuticals, product development processes, design controls, manufacturing and process validation, risk management, six sigma and design for six sigma, CA/PA, and materials. He is a certified Six Sigma black-belt, and has a strong track record in leading, managing, establishing and implementing growth and quality initiatives into client organizations around the world, resulting effective quality management systems and operational excellence. Dr. Sastri was on the faculty of the Association for the Advancement of Medical Instrumentation (AAMI) that provides training (along with the FDA) on the FDA Quality Systems Requirements and Industry Practice, Design Controls, Process Validation and Risk Management to the medical device industry. He now conducts public and in-house training through his company Winovia LLC. Prior to starting Winovia, Dr. Sastri held global leadership positions in technology, quality, manufacturing and marketing in companies including BASF, AlliedSignal and General Electric. He earned a Ph.D. from Rutgers University, completed post-doctoral work at Brooklyn Polytechnic Institute, and was an Adjunct Professor at Virginia Commonwealth University in Richmond, Virginia. Dr. Sastri has over 20 publications and 6 patents, and has presented at many international conferences and webinars in the United States, Europe, and Asia.

    Related to Plastics in Medical Devices

    Titles in the series (25)

    View More
    View More

    Related ebooks

    Technology & Engineering For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Packaging with Potential

      Sep 27, 2019

      Packaging with Potential
      2 min read

    • Article

      Opinion: From Bench To Bedside, Biologics Require Excellence At Every Stage

      Feb 13, 2020

      Quality and trust go together. As an industry, biologic manufacturers must deliver on quality. Public trust of sophisticated biological products will follow.

      3 min read

    • Article

      Opinion: Companies Must Responsibly Manufacture The Antimicrobials Society Needs

      Jan 30, 2020

      Providing access to antibiotics and other antimicrobials while reducing resistance to these medicines presents a dual manufacturing challenge: ensuring a cost-effective supply while minimizing their emission into the environment.

      4 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Opinion: Bringing Order To The ‘Wild Frontier’ Of Microbiome Medicine

      Oct 2, 2018

      When it comes to #microbiome medicine, @US_FDA and @NIH need to create a solid, science-based regulatory framework to help realize the promise of living drugs.

      4 min read

    • Article

      Opinion: FDA Is Smashing The Status Quo For Regulatory Science

      Oct 14, 2019

      The FDA can enable innovation by being a partner in advancing new approaches to drug development and regulatory science. Its recent reorganization signals a revolutionary shift in regulatory velocity.

      5 min read

    • Article

      How SA Regulates Medicines And Vaccines

      Feb 13, 2021

      COVID-19 has raised public awareness about the role of national medicines regulatory authorities in enabling access to safe, effective and quality-assured medicines. This includes vaccines. In South Africa, the pandemic has also exposed several impor

      4 min read

    • Article

      How SA Regulates Medicines And Vaccines

      Feb 13, 2021

      COVID-19 has raised public awareness about the role of national medicines regulatory authorities in enabling access to safe, effective and quality-assured medicines. This includes vaccines. In South Africa, the pandemic has also exposed several impor

      4 min read

    • Article

      How SA Regulates Medicines And Vaccines

      Feb 13, 2021

      COVID-19 has raised public awareness about the role of national medicines regulatory authorities in enabling access to safe, effective and quality-assured medicines. This includes vaccines. In South Africa, the pandemic has also exposed several impor

      4 min read

    • Article

      Opinion: Real-world Evidence Is Changing The Way We Study Drug Safety And Effectiveness

      Jan 29, 2019

      Instead of waiting for fleshed-out protocols for using real-world evidence, pharmaceutical companies should dive in now using a commonsense approach that relies on rigor and reason.

      4 min read

    • Article

      Opinion: U.S. Biologics And Biosimilars Need Distinguishable Names

      Apr 23, 2019

      Creating distinguishable nonproprietary names for biologics and their biosimilars will help ensure that patients get the right medications and will be useful for identifying adverse events more readily.

      5 min read

    • Article

      Opinion: Real-world Data Can Help Make Better Drugs And Do It Faster

      May 2, 2018

      Relying solely on clinical trials to demonstrate the safety and effectiveness of new drugs can be risky. Real-world data can help.

      4 min read

    • Article

      Opinion: Diagnostic Innovations Are Slowed By Bureaucratic Roadblocks

      Jan 18, 2019

      It's a long and winding road to bringing diagnostic innovations to the U.S. market. We need to clear the roadblocks.

      5 min read

    • Article

      On EPA Scientific Integrity, Wall Street Journal is Short of Facts

      May 26, 2017

      An opinion piece in today’s Wall Street Journal misrepresents the facts about an annual meeting on scientific integrity at the EPA and the role of the EPA scientific integrity officer. Here are some details about what that meeting is and the role of

      3 min read

    • Article

      Opinion: For Medicine Regulators, Reliance Is A Global Imperative

      Feb 27, 2020

      A new report from the U.S. National Academies, "Regulating Medicines in a Globalized World," shows how regulatory authorities can work together and avoid duplication.

      4 min read

    • Article

      Roundup: Movement on Agency Scientific Integrity Policies

      Oct 24, 2023

      How is scientific integrity being protected at federal agencies? Liz Borkowski offers the latest roundup.

      6 min read

    • Article

      Opinion: The FDA Needs To Set Standards For Using Artificial Intelligence In Drug Development

      Nov 7, 2019

      Poorly constructed AI algorithms for drug discovery and testing have the potential to cause harm. The FDA should play an important role in ensuring that AI-based drug development tools meet…

      3 min read

    Related categories

    Reviews for Plastics in Medical Devices

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words